SB 645 restructures Maryland's State Board of Sign Language Interpreters by expanding its membership from seven to 11 members with specific representation requirements, including a deafblind individual, deaf community members, licensed interpreters from various settings (legal, medical, educational), and ex-officio members from disability and labor agencies. The bill requires the Board to establish licensing requirements for sign language interpreters by December 31, 2026 (previously July 1, 2024), and mandates interpreters to meet these standards by that date. It also adds new grounds for the Governor to remove board members, including two consecutive unexcused absences or failing to attend 50% of meetings annually. These changes aim to improve board diversity, clarify licensing timelines, and ensure board members meet ongoing eligibility criteria.
HB 1483 repeals Maryland's requirement for out-of-state clinical counselors to obtain a temporary telehealth license. It allows licensed counselors from other states to provide telehealth counseling to clients who relocated to Maryland (or returned after relocating), for up to six months, if they already had an established client-counselor relationship before the move. This exempts these counselors from Maryland's standard licensure rules during the six-month continuity period, but only for existing clients who relocated - not for new clients. The bill does not change regular licensing requirements for ongoing practice in Maryland.
HB 1135 allows pharmacists in Maryland to order certain vaccinations for patients aged 3 and older without needing to administer the vaccine themselves. Pharmacists must complete 20+ hours of approved training covering vaccine safety, injection techniques, and emergency response, hold current CPR certification, and report all vaccinations to the ImmuNet program. The bill specifically covers influenza, COVID-19, and emergency-use vaccines, and requires pharmacists to refer minors to pediatric care when ordering vaccines. This expands pharmacists' role in vaccine access while maintaining safety protocols and reporting requirements.
SB 915 requires individuals performing limited X-ray procedures (such as chest, spine, and limb imaging) in Maryland to register with the State Board of Physicians. It restricts these operations to non-invasive X-rays only (excluding CT scans, mammography, or fluoroscopy) and mandates 115 hours of specialized training plus 6 months of clinical experience. The bill also establishes disciplinary procedures for violations and allows physician assistants to perform X-ray duties under physician supervision, while updating rules for cardiovascular specialists and medical graduates. This directly affects medical staff, radiologic technicians, and physician assistants conducting basic X-ray services in clinical settings.
SB 778 creates a new "clinical research pharmacy permit" required for pharmacies conducting clinical trials in Maryland. It allows healthcare providers to own such pharmacies under specific conditions, including requiring a licensed pharmacist to be on-site at all times and prohibiting owners from receiving payment for patient referrals. The bill also exempts clinical trials conducted by corporations from being classified as "practice of medicine," removing a licensing barrier for these activities. This directly affects pharmacies seeking to operate clinical trials, healthcare providers considering ownership, and the State Board of Pharmacy (as the permit issuer).
SB 159 requires Maryland's Emergency Medical Services (EMS) providers to maintain specific equipment and supplies on ambulances, including neonatal care items, and mandates quarterly reviews of performance data like response times and service quality. It also requires counties to establish formal, accessible complaint systems for ambulance quality or conduct issues, with online and in-person filing, tracking, and quarterly reporting to the state EMS Institute. These provisions directly affect all counties and municipalities operating or contracting EMS services, as well as the Maryland Institute for EMS Systems, which coordinates the statewide standards. The bill aims to standardize ambulance equipment, improve accountability through data reviews, and enhance patient access to complaint resolution. It takes effect July 1, 2026.
HB 347 adds hypertension to the list of occupational diseases presumed work-related for specific emergency responders in Maryland. It creates a legal presumption that firefighters, firefighting instructors, rescue squad members, advanced life support unit members, and State Fire Marshal staff with hypertension are entitled to workers' compensation benefits if they meet four conditions: diagnosed by a provider, prescribed hypertension medication for 90+ consecutive days, completed 2+ years of cumulative service in the state, and are currently employed in that role. This bill modifies Maryland’s workers’ compensation law (specifically Sections 9-502 and 9-503) to expand eligibility for these occupations without requiring separate proof that hypertension resulted from their job duties. It directly affects these emergency personnel seeking compensation for hypertension-related disability or death.
SB 96 updates terminology in Maryland's Sheila E. Hixson Behavioral Health Services Matching Grant Program by removing the word "active" before "service member" throughout the law. This change clarifies that the program serves all service members (including those not currently on active duty), veterans, and their families, without altering eligibility criteria or funding. The bill specifically revises definitions in Section 7.5-210(a)(2)(i), (b)(2), and (e)(1)(ii) to replace "active service member" with "service member." It does not create new benefits or change who qualifies for grants, only how the program describes its target population. The change aims to align the law with the program's actual scope and improve clarity.
HB 446 establishes the Dementia Services and Brain Health Program within Maryland’s Department of Health to lead state public health efforts on brain health and dementia. The program replaces the previous "Director" role for key duties, including staffing the Virginia I. Jones Alzheimer’s Disease and Related Dementias Council and overseeing implementation of the State Plan on Alzheimer’s and related dementias. It requires the program, in partnership with the Department of Aging and other entities, to develop a clinical toolkit for healthcare providers to improve dementia care. The bill updates existing law to formalize this program structure and its responsibilities.
HB 422 expands Maryland's expedited partner therapy (EPT) program to include bacterial vaginosis (BV), allowing certain healthcare providers to prescribe antibiotics to a partner of a diagnosed patient without requiring a physical exam of the partner. The bill specifically adds BV to the list of conditions (alongside chlamydia, gonorrhea, and trichomoniasis) where physicians, nurse practitioners, physician assistants, and designated health department nurses can provide treatment to partners. This applies to patients diagnosed with BV, aiming to reduce reinfection and slow disease spread without requiring partners to visit a clinic. The law takes effect October 1, 2026.